What to expect at the Clinical Quality Oversight Forum

Expect to be engaged, educated and inspired during this three-day virtual experience. Through presentations, panels, interactive discussions and exclusive roundtables, you’ll leave this virtual experience feeling connected to your peers and educated on where we stand as an industry, as we navigate the operational challenges resulting from the global pandemic.

Now in our 11th Year, the Clinical Quality Oversight Forum goes virtual with a three-day, online experience that you can watch in real time, to engage our expert speakers and be involved in all of the interactive activities, or on-demand with the recoded version. During this virtual experience, you’ll have the opportunity to interact with your peers and engage with our expert speaking faculty. Leave the event with a robust knowledge on where we stand as an industry with clinical quality and remote oversight of our partners, and an understanding of the path forward.

  Who Attends

This conference attracts SVPs, VPs, Directors, Heads, and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include:

Quality Management/Clinical Quality Management

Clinical Outsourcing/Vendor Management/ThirdParty Management

Clinical Quality Assurance/QA/CQA

Good Clinical Practice/GCP

Clinical Quality Control/QC/CQC


Clinical Operations/Management/Research/ Development


Compliance/Clinical Compliance/Regulatory Compliance

Clinical Risk/Risk Assessment

Monitoring/Site Management/Study Management

Regulatory/ Medical Affairs

Past Participants of Clinical Quality Oversight Forum


Daiichi Sankyo




Momenta Pharmaceuticals


Ironwood Pharmaceuticals

Regeneron Pharmaceuticals

Biomarin Pharmaceuticals Inc.

Janssen Pharmaceuticals

Sage Therapeuticals

Bill and Melinda Gates Medical Research Institute

Jazz Pharmaceuticals

Spark Therapeuticals

Boehringer Ingelheim

Johnson & Johnson


Clovis Oncology


United Therapeutics

CSL Behring


Zynerba Pharmaceuticals